Optimisation of the Cellular Metabolism of Glycosylation for Recombinant Proteins Produced by Mammalian Cell Systems

Many biopharmaceuticals are now produced as secreted glycoproteins from mammalian cell culture. The glycosylation profile of these proteins is essential to ensure structural stability and biological and clinical activity. However, the ability to control the glycosylation is limited by our understanding of the parameters that affect the heterogeneity of added glycan structures. It is clear that the glycosylation process is affected by a number of factors including the 3-dimensional structure of the protein, the enzyme repertoire of the host cell, the transit time in the Golgi and the availability of intracellular sugar-nucleotide donors. From a process development perspective there are many culture parameters that can be controlled to enable a consistent glycosylation profile to emerge from each batch culture. A further, but more difficult goal is to control the culture conditions to enable the enrichment of specific glycoforms identified with desirable biological activities. The purpose of this paper is to discuss the cellular metabolism associated with protein glycosylation and review the attempts to manipulate, control or engineer this metabolism to allow the expression of human glycosylation profiles in producer lines such as genetically engineered Chinese hamster ovary (CHO) cells.

[1]  Keiichiro Suzuki,et al.  High expression of α‐1‐6 fucosyltransferase during rat hepatocarcinogenesis , 1998 .

[2]  J. Vliegenthart,et al.  Structural analysis of the sialylated N- and O-linked carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. Sialylation patterns and branch location of dimeric N-acetyllactosamine units. , 1995, European journal of biochemistry.

[3]  R. Rodriguiz,et al.  Recombinant human interferon gamma therapy for osteopetrosis. , 1992, The Journal of pediatrics.

[4]  Ari Helenius,et al.  Quality control in the endoplasmic reticulum , 2003, Nature Reviews Molecular Cell Biology.

[5]  Gregory Stephanopoulos,et al.  Metabolic effects on recombinant interferon‐γ glycosylation in continuous culture of Chinese hamster ovary cells , 1999 .

[6]  H. Naim,et al.  Intracellular Folding of Tissue-type Plasminogen Activator , 1995, The Journal of Biological Chemistry.

[7]  S. Yamashita,et al.  Ectopic expression of alpha1,6 fucosyltransferase in mice causes steatosis in the liver and kidney accompanied by a modification of lysosomal acid lipase. , 2001, Glycobiology.

[8]  S. Kornfeld,et al.  Glucose starvation alters lipid-linked oligosaccharide biosynthesis in Chinese hamster ovary cells. , 1981, The Journal of biological chemistry.

[9]  M. Butler,et al.  The Effect of Cell Culture Parameters on Protein Glycosylation , 2002 .

[10]  R B Freedman,et al.  Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells. , 2001, Biotechnology and bioengineering.

[11]  W. C. Wang,et al.  The poly-N-acetyllactosamines attached to lysosomal membrane glycoproteins are increased by the prolonged association with the Golgi complex. , 1991, The Journal of biological chemistry.

[12]  A. Prince,et al.  Defective acidification of intracellular organelles in cystic fibrosis , 1991, Nature.

[13]  R Apweiler,et al.  On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. , 1999, Biochimica et biophysica acta.

[14]  M. Glick,et al.  Purification and characterization of GDP-L-fucose-N-acetyl beta-D-glucosaminide alpha 1----6fucosyltransferase from cultured human skin fibroblasts. Requirement of a specific biantennary oligosaccharide as substrate. , 1991, The Journal of biological chemistry.

[15]  M. Butler,et al.  Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation. , 2000, Biotechnology and bioengineering.

[16]  P. Newell,et al.  An IgG monoclonal antibody against Dictyostelium discoideum glycoproteins specifically recognizes Fucalpha1,6GlcNAcbeta in the core of N-linked glycans. Localized expression of core-fucosylated glycoconjugates in human tissues. , 1997, The Journal of biological chemistry.

[17]  Zachary Shriver,et al.  Glycomics: a pathway to a class of new and improved therapeutics , 2004, Nature Reviews Drug Discovery.

[18]  P. Storring.  Assaying glycoprotein hormones--the influence of glycosylation on immunoreactivity. , 1992, Trends in biotechnology.

[19]  Mark B. Jones,et al.  Characterization of the cellular uptake and metabolic conversion of acetylated N‐acetylmannosamine (ManNAc) analogues to sialic acids , 2004, Biotechnology and bioengineering.

[20]  C. Hirschberg.  Golgi nucleotide sugar transport and leukocyte adhesion deficiency II. , 2001, The Journal of clinical investigation.

[21]  R. Dwek,et al.  Concepts and principles of O-linked glycosylation. , 1998, Critical reviews in biochemistry and molecular biology.

[22]  L. Hunt,et al.  Sindbis virus glycoproteins are abnormally glycosylated in Chinese hamster ovary cells deprived of glucose. , 1985, The Journal of general virology.

[23]  C. Goochee.  Bioprocess factors affecting glycoprotein oligosaccharide structure. , 1992, Developments in biological standardization.

[24]  M. Butler,et al.  Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody. , 1998, Journal of biotechnology.

[25]  N Jenkins,et al.  Glycosylation of recombinant proteins: problems and prospects. , 1994, Enzyme and microbial technology.

[26]  A. Imberty,et al.  Conserved structural features in eukaryotic and prokaryotic fucosyltransferases. , 1998, Glycobiology.

[27]  N J Stark,et al.  Glucose-dependent glycosylation of secretory glycoprotein in mouse myeloma cells. , 1979, Archives of biochemistry and biophysics.

[28]  Nigel Jenkins,et al.  Getting the glycosylation right: Implications for the biotechnology industry , 1996, Nature Biotechnology.

[29]  K. Rice,et al.  Influence of core fucosylation on the flexibility of a biantennary N-linked oligosaccharide. , 1996, Biochemistry.

[30]  B. Weintraub,et al.  Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells. , 1991, Endocrinology.

[31]  J. Vliegenthart,et al.  Clonal analysis of the glycosylation of immunoglobulin G secreted by murine hybridomas. , 1989, Biochemistry.

[32]  J E Bailey,et al.  A mathematical model of N-linked glycoform biosynthesis. , 1997, Biotechnology and bioengineering.

[33]  T. Arakawa,et al.  The effect of carbohydrate on the structure and stability of erythropoietin. , 1991, The Journal of biological chemistry.

[34]  G. Ashwell,et al.  The asialoglycoprotein receptor: properties and modulation by ligand. , 1989, Progress in clinical and biological research.

[35]  N Taniguchi,et al.  Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-beta-D-glucosaminide:alpha1-6 fucosyltransferase (alpha1-6 FucT) from human gastric cancer MKN45 cells. , 1997, Journal of biochemistry.

[36]  M. Butler,et al.  The effect of dissolved oxygen on the metabolic profile of a murine hybridoma grown in serum-free medium in continuous culture. , 1997, Biotechnology and bioengineering.

[37]  J. Bailey,et al.  Synthesis of bisected glycoforms of recombinant IFN-beta by overexpression of beta-1,4-N-acetylglucosaminyltransferase III in Chinese hamster ovary cells. , 1998, Biotechnology progress.

[38]  D. Combes,et al.  In vitro glycosylation of proteins: an enzymatic approach. , 1996, Journal of biotechnology.

[39]  L. Silengo,et al.  Defective intracellular activity of GDP‐d‐mannose‐4,6‐dehydratase in leukocyte adhesion deficiency type II syndrome , 1998, FEBS letters.

[40]  James E. Bailey,et al.  Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity , 1999, Nature Biotechnology.

[41]  M. Butler,et al.  The effect of pH on the toxicity of ammonia to a murine hybridoma. , 1990, Journal of biotechnology.

[42]  H. Gabius,et al.  Eukaryotic glycosylation: whim of nature or multipurpose tool? , 1999, Cellular and Molecular Life Sciences CMLS.

[43]  K. Shitara,et al.  The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity* , 2003, The Journal of Biological Chemistry.

[44]  G. Longmore,et al.  Product-identification and substrate-specificity studies of the GDP-L-fucose:2-acetamido-2-deoxy-beta-D-glucoside (FUC goes to Asn-linked GlcNAc) 6-alpha-L-fucosyltransferase in a Golgi-rich fraction from porcine liver. , 1982, Carbohydrate research.

[45]  J. Bailey,et al.  Synthesis of Bisected Glycoforms of Recombinant IFN‐β by Overexpression of β‐1,4‐N‐Acetylglucosaminyltransferase III in Chinese Hamster Ovary Cells , 1998 .

[46]  Ylva Gavel,et al.  Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering , 1990, Protein engineering.

[47]  R. Dwek,et al.  Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. , 1997, Biochemistry.

[48]  Kouhei Tsumoto,et al.  Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. , 2004, Journal of molecular biology.

[49]  W. Gahl,et al.  Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme. , 1999, American journal of human genetics.

[50]  M. Spellman,et al.  Carbohydrate characterization of recombinant glycoproteins of pharmaceutical interest. , 1990, Analytical chemistry.

[51]  J. Lofgren,et al.  Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins , 1999, Nature Biotechnology.

[52]  C. Hoy,et al.  Multiple cell culture factors can affect the glycosylation of Asn-184 in CHO-produced tissue-type plasminogen activator. , 2000, Biotechnology and bioengineering.

[53]  N. Hooper,et al.  Glycosylation efficiency of Asn-Xaa-Thr sequons is independent of distance from the C-terminus in membrane dipeptidase. , 2003, Glycobiology.

[54]  J. Moskal,et al.  Transfection of 2,6 and 2,3‐sialyltransferase genes and GlcNAc‐transferase genes into human glioma cell line U‐373 MG affects glycoconjugate expression and enhances cell death , 2004, Journal of neurochemistry.

[55]  Gregory D. Longmore,et al.  Product-identification and substrate-specificity studies of the GDP-l-fucose: 2-acetamido-2-deoxy-β-d-glucoside (fuc→asn-linked GlcNAc) 6-α-l-fucosyltransferase in a golgi-rich fraction from porcine liver☆ , 1982 .

[56]  S. Fujii,et al.  Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1-->6fucosyltransferase. , 1996, The Journal of biological chemistry.

[57]  T. Raju,et al.  Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. , 2000, Glycobiology.

[58]  D. Andersen,et al.  Recombinant protein expression for therapeutic applications. , 2002, Current opinion in biotechnology.

[59]  Danny Chee Furng Wong,et al.  Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures. , 2005, Biotechnology and bioengineering.

[60]  G. Stephanopoulos,et al.  The effect of protein synthesis inhibitors on the glycosylation site occupancy of recombinant human prolactin , 1994 .

[61]  R. Wagner,et al.  Ammonium ion and glucosamine dependent increases of oligosaccharide complexity in recombinant glycoproteins secreted from cultivated BHK-21 cells. , 1998, Biotechnology and bioengineering.

[62]  L. Sturla,et al.  Synthesis of GDP-L-fucose by the Human FX Protein* , 1996, The Journal of Biological Chemistry.

[63]  A. Kobata,et al.  Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. , 1989, The Journal of biological chemistry.

[64]  H. Tachibana,et al.  Building high affinity human antibodies by altering the glycosylation on the light chain variable region in N-acetylglucosamine-supplemented hybridoma cultures , 2004, Cytotechnology.

[65]  C. Goochee,et al.  The effect of cell-culture conditions on the oligosaccharide structures of secreted glycoproteins. , 1994, Current opinion in biotechnology.

[66]  B Overdijk,et al.  The effect of increasing nucleotide-sugar concentrations on the incorporation of sugars into glycoconjugates in rat hepatocytes. , 1995, The Biochemical journal.

[67]  C. Ohyama,et al.  Molecular Cloning and Expression of GDP-d-mannose-4,6-dehydratase, a Key Enzyme for Fucose Metabolism Defective in Lec13 Cells* , 1998, The Journal of Biological Chemistry.

[68]  L. Presta,et al.  Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.

[69]  R. Dwek,et al.  Glycosylation: heterogeneity and the 3D structure of proteins. , 1997, Critical reviews in biochemistry and molecular biology.

[70]  J. Davies,et al.  Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII. , 2001, Biotechnology and bioengineering.

[71]  G. Hughes,et al.  Rapid structural characterisation of a murine monoclonal IgA alpha chain: heterogeneity in the oligosaccharide structures at a specific site in samples produced in different bioreactor systems. , 1999, Journal of biotechnology.

[72]  R. Wagner,et al.  Incorporation of ammonium into intracellular UDP-activated N-acetylhexosamines and into carbohydrate structures in glycoproteins. , 1999, Biotechnology and bioengineering.

[73]  L Xie,et al.  Integrated approaches to the design of media and feeding strategies for fed-batch cultures of animal cells. , 1997, Trends in biotechnology.

[74]  Evon M. O. Abu-Taieh,et al.  Comparative Study , 2020, Definitions.

[75]  R. Knop,et al.  Ammonia inhibits neural cell adhesion molecule polysialylation in Chinese hamster ovary and small cell lung cancer cells , 1998, Journal of cellular physiology.

[76]  Masaaki Goto,et al.  Production of Recombinant Human Erythropoietin in Mammalian Cells: Host–Cell Dependency of the Biological Activity of the Cloned Glycoprotein , 1988, Bio/Technology.

[77]  J. Bailey,et al.  Engineering of coordinated up- and down-regulation of two glycosyltransferases of the O-glycosylation pathway in Chinese hamster ovary (CHO) cells. , 2000, Biotechnology and bioengineering.

[78]  H. Miyazaki,et al.  Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells. , 1988, The Journal of biological chemistry.

[79]  C. Goochee,et al.  The effect of ammonia on the O‐linked glycosylation of granulocyte colony‐stimulating factor produced by chinese hamster ovary cells , 1995, Biotechnology and bioengineering.

[80]  S. Kornfeld,et al.  Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.

[81]  R. Wagner,et al.  Intracellular UDP−N‐Acetylhexosamine Pool Affects N‐Glycan Complexity: A Mechanism of Ammonium Action on Protein Glycosylation , 1998, Biotechnology progress.

[82]  J. Dennis,et al.  The extent of polylactosamine glycosylation of MDCK LAMP-2 is determined by its Golgi residence time. , 1998, Glycobiology.

[83]  M. Krieger,et al.  The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin. , 1991, Blood.

[84]  Daniel I. C. Wang,et al.  Improvement of interferon-gamma sialylation in Chinese hamster ovary cell culture by feeding of N-acetylmannosamine. , 1998, Biotechnology and bioengineering.

[85]  Z. Erbayraktar,et al.  Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[86]  P. P. Gray,et al.  Role of environmental conditions on the expression levels, glycoform pattern and levels of sialyltransferase for hFSH produced by recombinant CHO cells , 2004, Cytotechnology.

[87]  Naoyuki Taniguchi,et al.  Purification and cDNA Cloning of Porcine Brain GDP-L-Fuc:N-Acetyl-β-D-Glucosaminide α1→6Fucosyltransferase* , 1996, The Journal of Biological Chemistry.

[88]  J. Briggs,et al.  Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues. , 2001, Biochemistry.

[89]  H. Asakura,et al.  Structural analysis on the sugar chains of human alpha 1-antitrypsin: presence of fucosylated biantennary glycan in hepatocellular carcinoma. , 1993, Archives of biochemistry and biophysics.

[90]  Chi‐Huey Wong,et al.  Enzyme action in glycoprotein synthesis , 1998, Cellular and Molecular Life Sciences CMLS.

[91]  G. Distefano,et al.  A new Chinese hamster ovary cell line expressing alpha2,6-sialyltransferase used as universal host for the production of human-like sialylated recombinant glycoproteins. , 2000, Biochimica et biophysica acta.

[92]  W. Lennarz,et al.  Unraveling the Mechanism of Protein N-Glycosylation* , 2005, Journal of Biological Chemistry.

[93]  A. Bull,et al.  Glucose‐limited chemostat culture of chinese hamster ovary cells producing recombinant human interferon‐γ , 1992, Biotechnology and bioengineering.

[94]  L. Foddy,et al.  Assembly of asparagine-linked oligosaccharides in baby hamster kidney cells treated with castanospermine, an inhibitor of processing glucosidases. , 1988, European journal of biochemistry.

[95]  M. Butler.  Animal Cell Culture and Technology , 1997 .

[96]  L. Taylor,et al.  Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal alpha-linked galactose. , 1997, Analytical biochemistry.

[97]  Y. Ikeda,et al.  α1,6fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas , 2000, International journal of cancer.

[98]  K. Gull,et al.  Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture. , 1990, The Biochemical journal.

[99]  N Taniguchi,et al.  Overexpression of alpha1-6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice. , 1999, Cancer research.

[100]  Dirk Lütkemeyer,et al.  Effects of dissolved oxygen levels and the role of extra- and intracellular amino acid concentrations upon the metabolism of mammalian cell lines during batch and continuous cultures , 1998, Cytotechnology.

[101]  N. Kochibe,et al.  Comparative study of the asparagine-linked sugar chains of natural human interferon-beta 1 and recombinant human interferon-beta 1 produced by three different mammalian cells. , 1988, The Journal of biological chemistry.

[102]  R. Wagner,et al.  Characterization of changes in the glycosylation pattern of recombinant proteins from BHK-21 cells due to different culture conditions. , 1995, Journal of biotechnology.

[103]  Eleftherios T. Papoutsakis,et al.  Culture pH Affects Expression Rates and Glycosylation of Recombinant Mouse Placental Lactogen Proteins by Chinese Hamster Ovary (CHO) Cells , 1993, Bio/Technology.

[104]  Raymond A Dwek,et al.  Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding. , 2003, Glycobiology.

[105]  J. Egrie,et al.  Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin. , 2003, Experimental hematology.

[106]  B. van den Hazel,et al.  Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone. , 2003, The Journal of clinical endocrinology and metabolism.

[107]  R. Dwek,et al.  Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis. , 2003, Glycobiology.

[108]  Jennifer S Griffiths,et al.  Gene-expression profiles for five key glycosylation genes for galactose-fed CHO cells expressing recombinant IL-4/13 cytokine trap. , 2005, Biotechnology and bioengineering.

[109]  Reed J. Harris,et al.  Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. , 1990, The Journal of biological chemistry.

[110]  M. Butler,et al.  The effects of glutamine utilisation and ammonia production on the growth of BHK cells in microcarrier cultures , 1984 .

[111]  J. Taylor‐Papadimitriou,et al.  Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells. , 2003, The Biochemical journal.

[112]  A. Varki,et al.  Chemical Diversity in the Sialic Acids and Related α-Keto Acids: An Evolutionary Perspective , 2002 .